Increased excitatory amino acid transport into murine prion protein knockout astrocytes cultured in vitro

GLIA

Volumn 59, Issue 11, 2011, Pages 1684-1694

  Pathmajeyan, Melissa S ^a,b   Patel, Sarjubhai A ^b   Carroll, James A ^a   Seib, Todd ^b   Striebel, James F ^a   Bridges, Richard J ^b   Chesebro, Bruce ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

Astrocyte; Excitatory amino acid transporters; Excitotoxicity; NMDA receptor; Prion protein

Indexed keywords

ASPARTIC ACID; EXCITATORY AMINO ACID; PRION PROTEIN;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL SURVIVAL; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY;

ANIMALS; ASPARTIC ACID; ASTROCYTES; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; FLOW CYTOMETRY; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PRIONS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM;

EID: 80052820797     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21215     Document Type: Article

References (60)

1. Adolph O, Koster S, Rath M, Georgieff M, Weigt HU, Engele J, Senftleben U, Fohr KJ. 2007. Rapid increase of glial glutamate uptake via blockade of the protein kinase A pathway. Glia 55: 1699-1707.
2. Aguzzi A, Baumann F, Bremer J. 2008. The prion's elusive reason for being. Annu Rev Neurosci 31: 439-477.
3. Anderson CM, Swanson RA. 2000. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions. Glia 32: 1-14.
4. Beart PM, O'shea RD. 2007. Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150: 5-17.
5. Bridges RJ, Esslinger CS. 2005. The excitatory amino acid transporters: Pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes. Pharmacol Ther 107: 271-285.
6. Brown DR, Mohn CM. 1999. Astrocytic glutamate uptake and prion protein expression. Glia 25: 282-292.
7. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C. 1992. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577-582.
8. Butchbach ME, Tian G, Guo H, Lin CL. 2004. Assocation of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: Importance for excitatory amino acid transporter localization and function. J Biol Chem 279: 34388-34396.
9. Carleton A, Tremblay P, Vincent JD, Lledo PM. 2001. Dose-dependent, prion protein (PrP)-mediated facilitation of excitatory synaptic transmission in the mouse hippocampus. Pflugers Arch 442: 223-229.
10. Choi DW. 1992. Excitotoxic cell death. J Neurobiol 23: 1261-1276.
11. Choi DW, Maulucci-Gedde M, Kriegstein AR. 1987. Glutamate neurotoxicity in cortical cell culture. J Neurosci 7: 357-368.
12. Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL. 1992. The time course of glutamate in the synaptic cleft. Science 258: 1498-1501.
13. Coitinho AS, Dietrich MO, Hoffmann A, Dall'Igna OP, Souza DO, Martins VR, Brentani RR, Izquierdo I, Lara DR. 2002. Decreased hyperlocomotion induced by MK-801, but not amphetamine and caffeine in mice lacking cellular prion protein (PrP(C)). Brain Res Mol Brain Res 107: 190-194.
14. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. 1994. Prion protein is necessary for normal synaptic function. Nature 370: 295-297.
15. Criado JR, Sanchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, Race R, Manson JC, Chesebro B, Oldstone MB. 2005. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 19: 255-265.
16. Daginakatte GC, Gadzinski A, Emnett RJ, Stark JL, Gonzales ER, Yan P, Lee JM, Cross AH, Gutmann DH. 2008. Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines. Exp Neurol 210: 261-267.
17. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65: 1-105.
18. Diamond JS. 2005. Deriving the glutamate clearance time course from transporter currents in CA1 hippocampal astrocytes: Transmitter uptake gets faster during development. J Neurosci 25: 2906-2916.
19. Duan S, Anderson CM, Stein BA, Swanson RA. 1999. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci 19: 10193-10200.
20. Dzubay JA, Otis TS. 2002. Climbing fiber activation of metabotropic glutamate receptors on cerebellar purkinje neurons. Neuron 36: 1159-1167.
21. Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ. 2005. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Neuropharmacology 49: 850-861.
22. Eulenburg V, Gomeza J. 2010. Neurotransmitter transporters expressed in glial cells as regulators of synapse function. Brain Res Rev 63: 103-112.
23. Gegelashvili G, Danbolt NC, Schousboe A. 1997. Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia. J Neurochem 69: 2612-2615.
24. Hakuba N, Koga K, Gyo K, Usami SI, Tanaka K. 2000. Exacerbation of noise-induced hearing loss in mice lacking the glutamate transporter GLAST. J Neurosci 20: 8750-8753.
25. Herman MA, Jahr CE. 2007. Extracellular glutamate concentration in hippocampal slice. J. Neurosci. 27: 9736-9741.
26. Hosli E, Otten U, Hosli L. 1997. Expression of GABA(A) receptors by reactive astrocytes in explant and primary cultures of rat CNS. Int J Dev Neurosci 15: 949-960.
27. Huang YH, Sinha SR, Tanaka K, Rothstein JD, Bergles DE. 2004. Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons. J Neurosci 24: 4551-4559.
28. Jackson M, Song W, Liu MY, Jin L, Dykes-Hoberg M, Lin CI, Bowers WJ, Federoff HJ, Sternweis PC, Rothstein JD. 2001. Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature 410: 89-93.
29. Jackson MJ, Zielke HR, Max SR. 1995. Effect of dibutyryl cyclic AMP, dexamethasone on glutamine synthetase gene expression in rat astrocytes in culture. Neurochem Res 20: 201-207.
30. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. 2005. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia and seizures. Neurology 65: 529-534.
31. Kaech S, Banker G. 2006. Culturing hippocampal neurons. Nat Protoc 1: 2406-2415.
32. Khelil M, Rolland B, Fages C, Tardy M. 1990. Glutamine synthetase modulation in astrocyte cultures of different mouse brain areas. Glia 3: 75-80.
33. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, Zamponi GW. 2008. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 181: 551-565.
34. Koch HP, Kavanaugh MP, Esslinger CS, Zerangue N, Humphrey JM, Amara SG, Chamberlin AR, Bridges RJ. 1999. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol Pharmacol 56: 1095-1104.
35. Le Prince G, Fages C, Rolland B, Nunez J, Tardy M. 1991. DBcAMP effect on the expression of GFAP and of its encoding mRNA in astroglial primary cultures. Glia 4: 322-326.
36. Lin CI, Orlov I, Ruggiero AM, Dykes-Hoberg M, Lee A, Jackson M, Rothstein JD. 2001. Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18. Nature 410: 84-88.
37. Mallucci GR, Ratte S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J. 2002. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. Embo J 21: 202-210.
38. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 1994. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8: 121-127.
39. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L. 1996. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40: 759-766.
40. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
41. Miele G, Alejo Blanco AR, Baybutt H, Horvat S, Manson J, Clinton M. 2003. Embryonic activation and developmental expression of the murine prion protein gene. Gene Expr 11: 1-12.
42. Miller S, Bridges RJ, Chamberlin AR, Cotman CW. 1994. Pharmacological dissociation of glutamatergic metabotropic signal transduction pathways in cortical astrocytes. Eur J Pharmacol 269: 235-241.
43. Miyamoto S, Duncan GE, Marx CE, Lieberman JA. 2005. Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10: 79-104.
44. Munir M, Correale DM, Robinson MB. 2000. Substrate-induced up-regulation of Na(+)-dependent glutamate transport activity. Neurochem Int 37: 147-162.
45. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A. 1997. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272: 6324-6331.
46. Race B, Meade-White K, Race R, Baumann F, Aguzzi A, Chesebro B. 2009. Prion protein on astrocytes or in extracellular fluid impedes neurodegeneration induced by truncated prion protein. Exp Neurol 217: 347-352.
47. Rauen T, Fischer F, Wiessner M. 1999. Glia-neuron interaction by high-affinity glutamate transporters in neurotransmission. Adv Exp Med Biol 468: 81-95.
48. Robinson MB, Djali S, Buchhalter JR. 1993. Inhibition of glutamate uptake with L-trans-pyrrolidine-2, 4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures. J Neurochem 61: 2099-2103.
49. Rosenberg PA, Aizenman E. 1989. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci Lett 103: 162-168.
50. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686.
51. Rothstein JD, Martin LJ, Kuncl RW. 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326: 1464-1468.
52. Sardar AM, Hutson PH, Reynolds GP. 1999. Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport 10: 3513-3515.
53. Schlag BD, Vondrasek JR, Munir M, Kalandadze A, Zelenaia OA, Rothstein JD, Robinson MB. 1998. Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol Pharmacol 53: 355-369.
54. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ. 2005. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171: 1001-1012.
55. Speliotes EK, Hartnett KA, Blitzblau RC, Aizenman E, Rosenberg PA. 1994. Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA. J Neurochem 63: 879-885.
56. Swanson RA, Liu J, Miller JW, Rothstein JD, Farrell K, Stein BA, Longuemare MC. 1997. Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci 17: 932-940.
57. Turecek R, Trussell LO. 2000. Control of synaptic depression by glutamate transporters. J Neurosci 20: 2054-2063.
58. Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, Inoue Y, Okuyama S, Sakagawa T, Ogawa S, Kawashima N, Hori S, Takimoto M, Wada K, Tanaka K. 1998. Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice. Eur J Neurosci 10: 976-988.
59. Williamson RA, Peretz D, Pinilla C, Ball H, Bastidas RB, Rozenshteyn R, Houghten RA, Prusiner SB, Burton DR. 1998. Mapping the prion protein using recombinant antibodies. J Virol 72: 9413-9418.
60. Yang Y, Gozen O, Watkins A, Lorenzini I, Lepore A, Gao Y, Vidensky S, Brennan J, Poulsen D, Park JW, Jeon NL, Robinson MB, Rothstein JD. 2009. Pre-synaptic regulation of astroglial excitatory neurotransmitter transporter GLT-1. Neuron 61: 880-894.